FDA inspection
Replimune Limited: FDA inspection ending Mar 26, 2025
FDA inspection 1273825 · Voluntary Action Indicated (VAI) · Oxford
Key facts
| Inspection ID | 1273825 |
|---|---|
| Firm | Replimune Limited |
| FEI number | 3014028551 |
| Address | 69 Innovation Drive |
| City | Oxford |
| Fiscal year | 2025 |
| Inspection end date | Mar 26, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data